You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 104 No. 2, AUGUST 1959 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Serotonin and the 5-Hydroxyindole Pathway of Tryptophan Metabolism

ROBERT M. DONALDSON, JR., M.D.; SEYMOUR J. GRAY, M.D., Ph.D.

AMA Arch Intern Med. 1959;104(2):330-338.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The presence of a vasopressor factor in clotted defibrinated blood has been known for 90 years. This factor, serotonin, was isolated from blood platelets and identified as 5-hydroxytryptamine in 1948, by Rapport. In 1937, enteramine, a smooth muscle constrictor which was later found to be identical with serotonin, was isolated from intestinal mucosa by Erspamer. He suggested that enteramine was a hormonal substance secreted by the argentaffin cells of the intestine. Intense interest in this entire subject was stimulated by recognition of the disease entity, malignant carcinoidosis. The syndrome is caused by malignant carcinoid tumors (argentaffinomas), which contain large quantities of serotonin. Patients with carcinoidosis have increased amounts of serotonin in the blood and large quantities of 5-hydroxyindoleacetic acid, the major metabolite of serotonin, in the urine. The clinical features of the carcinoid syndrome include episodic flushing of the skin, patchy cyanosis, telangiectasia, pellagra-like skin lesions, bronchoconstriction, edema, atypical valvular . . . [Full Text PDF of this Article]


Author Affiliations

Boston

From the Medical Clinic, Peter Bent Brigham Hospital, and the Department of Medicine, Harvard Medical School; Junior Associate in Medicine, Peter Bent Brigham Hospital, and Assistant in Medicine, Harvard Medical School (Dr. Donaldson); Physician, Peter Bent Brigham Hospital, and Associate Clinical Professor of Medicine, Harvard Medical School (Dr. Gray).


Footnotes

Submitted for publication Feb. 10, 1959.

This work was supported in part by grants from the United States Public Health Service and the Gastrointestinal Fund of the Peter Bent Brigham Hospital.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1959 American Medical Association. All Rights Reserved.